A German court ruled COVID-19 jab manufacturer AstraZeneca must provide comprehensive information regarding all known side effects of its experimental COVID-19 shot to a woman from Upper Franconia who suffered from thrombosis in the intestine and fell into a coma after receiving the AstraZeneca shot in March 2021.A partial victory was achieved by the woman before the Bamberg Higher Regional Court. On Monday‚ a civil chamber ruled that the company must provide comprehensive information regarding all known effects and side effects of its coronavirus vaccine‚ specifically those relevant to the plaintiffs clinical condition. This encompassed any additional findings gathered between the vaccines approval in December 2020 and February 2024‚The Munich Eyereports. AstraZeneca Ordered to Disclose Data Regarding its COVID Vaccine";Some individuals vaccinated experienced thrombosis in the brain or abdominal organs‚ resulting in fatalities"; @TheMunichEye https://t.co/L09PPMLOGi Childrens Health Defense (@ChildrensHD) April 12‚ 2024A court spokesperson reportedly said the disclosed information pertains solely to the womans illness and was only required to be made available to her.However‚ the plaintiffs lawyer believes the ruling will lead to further requests for information in similar cases.The Munich Eyenoted its the first trial of its kind in Germany.German woman gets initial win against #AstraZeneca #Covid #vaccine trial A civil chamber of the Bamberg Higher Regional Court‚ in Bavaria‚ ordered the company to provide comprehensive information about a possible side effects https://t.co/2qfxhetJMw (@x13x33) April 9‚ 2024The Munich Eye reports:The clinical condition of the plaintiff is referred to as thrombosis with thrombocytopenia syndrome (TTS). This severe thrombosis‚ occurring extremely rarely not only after vaccinations with Astrazenecas Covid vaccine but also with the similar vaccine from Johnson &;amp; Johnson‚ is accompanied by a decrease in blood platelets. It appears to stem from antibodies formed post-vaccination attacking the blood platelets. Both Astrazenecas and Johnson &;amp; Johnsons Covid vaccines are based on modified cold viruses.The frequency of TTS following vaccination with these vector vaccines is not precisely known but is established to be extremely rare. As of early April 2021‚ the European Medicines Agency had identified 169 cases of cerebral vein TTS and 53 cases of abdominal TTS among 34 million vaccinated individuals. Initially presumed to be more prevalent in younger individuals and women‚ it is now believed to affect the entire population uniformly.The civil case is one of the first in Germany against a coronavirus vaccine manufacturer‚ theDaily Sabahsaid.German court hands woman initial win in lawsuit against drugmaker AstraZeneca';s Covid-19 vaccine trialhttps://t.co/s4JAOJe3J4 Daily Sabah (@DailySabah) April 8‚ 2024From the Daily Sabah:The 33-year-old plaintiff had been vaccinated with AstraZenecas Covid-19 vaccine in March 2021 and subsequently suffered a so-called intestinal vein thrombosis. She went into a coma and ultimately had to have part of her intestine removed.Volker Loeschner‚ the womans lawyer‚ said they were happy about the the courts ruling requiring the disclosure.The data to be provided by AstraZeneca could be relevant for other ongoing and future trials‚ Loeschner said.The plaintiffs lawsuit for damages and compensation for pain and suffering is ongoing.